Results 151 to 160 of about 37,516 (275)

Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights

open access: yesAmerican Journal of Hematology, Volume 101, Issue 7, Page 1575-1588, July 2026.
CTC offer a minimally invasive widow into systemic myeloma biology, overcoming the sampling bias of bone marrow biopsies. Their prognostic value at diagnosis, potential role in MRD monitoring, and ability to capture clonal evolution highlight them as actionable biomarkers for future precision medicine.
Benjamin Podvin   +3 more
wiley   +1 more source

A Case of Isolated Extramedullary Plasmacytoma of the Sternoclavicular joint: A Rare Case Report

open access: yes
Yiwei Yan,1 Mingli Ouyang,2 Yongmei Han2 1Department of Rheumatology, Shaoxing Shangyu District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang Province, 312300, People’s Republic of China; 2Department of Rheumatology, Sir Run Run Shaw ...
Han Y, Yan Y, Ouyang M
core   +1 more source

Intracranial extramedullary hematopoiesis in a thalassemic girl: A Case report

open access: yes, 2017
Beta-thalassemia is a haemolytic disorder with ineffective erythropoiesis and red blood cell destruction. Extramedullary hematopoiesis is one of the complications associated with beta-thalassemia. Extramedullary hematopoiesis is the ectopic production of
Saini, Lalit   +4 more
core   +1 more source

Real‐World Outcomes of FLAG‐Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study

open access: yesAmerican Journal of Hematology, Volume 101, Issue 7, Page 1692-1705, July 2026.
ABSTRACT In a large multicenter real‐world cohort, we aimed to evaluate outcomes of FLAG‐Ida salvage therapy for relapsed/refractory (R/R) acute myeloid leukemia (AML) and validated the SALFLAGE prognostic score. We analyzed 1079 adults with R/R AML treated across 112 PETHEMA institutions over 26 years (1998–2024), including patients with primary ...
Gaspar Aspas Requena   +49 more
wiley   +1 more source

Visible Tongue Fasciculations With Electromyographic Denervation in Autopsy‐Proven Progressive Supranuclear Palsy Mimicking Amyotrophic Lateral Sclerosis

open access: yes
Muscle &Nerve, Volume 74, Issue 2, Page 496-499, August 2026.
Hiroyasu Inoue   +7 more
wiley   +1 more source

Acute Lymphoblastic Leukemia Presenting With Severe Acute Kidney Injury Requiring Hemodialysis due to Kidney Infiltration: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT A 66‐year‐old man presented with dialysis‐dependent acute kidney injury without cytopenia or peripheral blasts. Kidney biopsy revealed leukemic infiltration and led to the diagnosis of Philadelphia chromosome‐negative B‐acute lymphoblastic leukemia.
Semin Cho   +9 more
wiley   +1 more source

Pulmonary Leukemic Infiltration in Relapsed Acute Myeloid Leukemia: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Pulmonary leukemic infiltration (PLI) is a rare complication of acute myeloid leukemia often misdiagnosed as pneumonia. This case highlights a unique presentation of PLI in a relapsed patient without hyperleukocytosis, necessitating a high index of suspicion.
Masoud Mortezazadeh   +6 more
wiley   +1 more source

Salvage Therapy With Inotuzumab Ozogamicin in Relapsed/Refractory B‐ALL After CAR‐T Therapy and HSCT: A Case Series

open access: yesCancer Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background Although inotuzumab ozogamicin (InO) has been approved as an effective agent for patients with refractory/relapsed (r/r) B‐cell acute lymphoblastic leukemia (B‐ALL), data in the context of post chimeric antigen receptor (CAR)‐T cell therapy and allogeneic hematopoietic stem cell transplantation (allo‐HSCT) relapse are lacking.
Honghu Li   +8 more
wiley   +1 more source

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma

open access: yes
Cancer, Volume 132, Issue 14, 15 July 2026.
Heidi A. Worth, Luciano J. Costa
wiley   +1 more source

Idecabtagene vicleucel and endogenous T‐cell phenotypes linked to progression‐free survival in relapsed multiple myeloma

open access: yesHemaSphere, Volume 10, Issue 7, July 2026.
Abstract Improved understanding of how chimeric antigen receptor (CAR) and endogenous T‐cell phenotypes associate with progression‐free survival (PFS) is needed to individualize and improve immunotherapy outcomes in multiple myeloma (MM). We characterized and investigated the prognostic value of immune dynamics defined with multidimensional and ...
Bruno Paiva   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy